MEPs closer to agreement on EU patient information proposal
This article was originally published in Scrip
Executive Summary
The European Parliament is drawing nearer to agreement on the controversial EU proposal to allow pharmaceutical companies to provide drug information to patients. But the final result is likely to be a very watered down version of the European Commission's original proposal, with regulators exerting tight control over the narrow range of information materials that companies will be able to provide.